Leonard Weinstock, MD - Restless Legs Syndrome (2016 Conference) (LDN, low dose naltrexone)
In this presentation Dr Leonard Weinstock discusses the clinical importance of restless leg syndrome (RLS), the role that SIBO plays in RLS, Rifaximin studies, inflammation and endorphins and a study using sequential rifaximin and low dose naltrexone (LDN).
Dr Weinstock discusses how good current traditional treatments are and gives several case studies. He shows how endorphin deficiency affects RLS.
Dr Weinstock concludes that a multimodality treatment is often needed in RLS and low dose naltrexone (LDN) can play an important role in treatment.
For more presentations please visit https://ldnresearchtrust.org/ldn-conferences